Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Hackensack, New Jersey 07601


Purpose:

The objective of this study was to prove the bioequivalence of Famciclovir 500 mg Tablets under fasting conditions.


Criteria:

Inclusion Criteria: - No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Exclusion Criteria: - Positive test for HIV, Hepatitis B, or Hepatitis C. - Treatment with known enzyme altering drugs. - History of allergic or adverse response to famciclovir, penciclovir or any comparable or similar product.


NCT ID:

NCT01321515


Primary Contact:

Principal Investigator
Benno G Roesch, M.D.
Advanced Biomedical Research


Backup Contact:

N/A


Location Contact:

Hackensack, New Jersey 07601
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.